Israeli company takes photos of vital signs for better health

Vital signs offer medical professionals the first indication of our health. Measuring them is essential to assess a person’s well-being, to indicate whether a person might be suffering from an underlying disease, and to determine whether a treatment that the person might be receiving is effective.

The Israeli company Binah.ai can capture and extract a person’s vital signs ranging from heart rate, heart rate variability, oxygen saturation, and more through the camera of a smartphone, tablet, or laptop. one patient, all in less than a minute.

Its health data platform is powered by artificial intelligence and is a software-only solution, which means that it does not require any additional handheld devices or other dedicated hardware. The person’s vital signs are delivered to the user in a simple and accessible digital format.

“We want to make the world a healthier place,” said company founder and CEO David Maman.

Binah.ai was founded in 2017. At that time, according to the World Health Organization, up to 60% of humanity did not have access to the medical services they needed.

Binah.ai captures vital signs in less than a minute via camera (credit: BINAH.AI)

Maman said that today, most Western countries, including Israel, have about three doctors for every 1,000 people. But in some countries, including many in the Middle East, there is only one doctor for every 10,000 people. And in others, such as parts of Africa, there is one doctor on strike for every 30,000 people.

“The population growth is staggering,” Maman said. “And being a doctor is not easy. Smart people are choosing to make money from high tech and fewer and fewer are in medicine, which takes years of training and can be an extremely difficult profession unless they really have a calling. “

But while countries may lack available doctors, even in most of the world’s extremely disadvantaged countries, citizens often have smartphones.

    Binah.ai Founder and CEO David Maman (credit: BINAH.AI) Binah.ai Founder and CEO David Maman (credit: BINAH.AI)

Binah.ai, Maman explained, transforms these phones into medical devices through its software.

The system works by remote photoplethysmography (rPPG).

PPG (without the r) is a simple and inexpensive optical measurement method that was first discussed in the late 1930s. RPPG, on the other hand, is a “camera-based solution for non-contact cardiovascular monitoring, It has been proven to be as accurate as traditional PPG devices. Our technology measures changes in the red, green and blue light reflected by the skin and quantifies the contrast between specular reflection and diffuse reflection, ”explains the company’s website.

Binah.ai does not have access to customer data. Rather, your technology is embedded in your customers’ applications and data is only delivered to the user or where the user chooses to make it available. For example, a user could send the scans to their insurance company or doctor, “but it is up to the customers what to do with the data,” Maman emphasized.

The company aims to make people healthier, but it is also using its device to help the company assess the health of its customers. Its software is already in use by seven of the world’s top 100 insurance companies, who ask their users to confirm their vital signs to help determine customer health and set premiums.

Maman said 50 clients in total are using the technology, which offers eight vital sign measurements to date. The goal is to provide up to 25 long-term vital signs.

Although Binah.ai does not need the Food and Drug Administration to sell its software, the company plans to submit its software for FDA Class II medical device approval in December with the goal of receiving approval for at least two vital signs. early next year and then the rest after that. Maman said that having this approval “will dramatically increase the credibility of the system.”

“Our goal is to make everything medical grade,” he said.

In the future, primary care physicians wishing to access software could be envisioned as an effective means of preventive medicine. An elevated resting heart rate for a week can be a sign of increased mortality, for example, and doctors might see this warning sign early and advise their patients.

“It’s not just about reading vital signs, it’s about what they mean,” Maman said.

He added that biotechnology is not just “the next big thing, it is everything.”

Medical care was neglected, he said, and the coronavirus crisis returned the field to the forefront with a vengeance. It also prompted medical professionals to embrace telehealth and digital devices like never before.

Israel, he predicted, could be a leader in the arena.

“I expect the Israeli biotech market to triple in the next five years,” he said.



Reference-www.jpost.com

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *